RISK FACTORS AND INCIDENCE OF MYOCARDIAL DAMAGE IN PATIENTS WITH HEMOBLASTOSIS RECEIVING ANTHRACYCLIN ANTIBIOTICS

RISK FACTORS AND INCIDENCE OF MYOCARDIAL DAMAGE IN PATIENTS WITH HEMOBLASTOSIS RECEIVING ANTHRACYCLIN ANTIBIOTICS

Introduction. The anthracycline antibiotics cause clinically significant manifestations of cardiotoxicity (СТ) – myocardial injuries, reducing both quality and life expectancy of the oncological patients.The purpose of the study was to evaluate the incidence and risk factors anthracycline-induced СТ...

Full description

Bibliographic Details
Main Authors: N. T. Vatutin, E. V. Sklyannaya, M. A. El-Khatib, I. A. Sologub
Format: Article
Language:Russian
Published: ABV-press 2017-10-01
Series:Onkogematologiâ
Subjects:
chemotherapy
cardiotoxicity
anthracycline-induced cardiomyopathy
risk factors
cardioprotection
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/255

Internet

https://oncohematology.abvpress.ru/ongm/article/view/255

Similar Items